Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thromb... by Nazeri, S, Zakeri, S, Mehrizi, A, Djadid, N, Snounou, G, Andolina, C, Nosten, F

Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infect... by Shabani, S, Zakeri, S, Salmanian, A, Amani, J, Mehrizi, A, Snounou, G, Nosten, F, Andolina, C, Mourtazavi, Y, Djadid, N